There are many mechanisms that have been shown to contribute to changes in O-GalNAc glycosylation in breast cancer including relocalisation of GalNAc-Ts, changes in expression of GTs as well as altered glycosidase activity. The gene discussed is B4GALNT1; the disease is breast cancer.